OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2021
(7)
2022
(3)
2025
(2)
2016
(2)
2013
(2)
2023
(1)
2020
(1)
2019
(1)
2015
(1)
2014
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Not available
S-EPMC3593184
|
biostudies-literature
Cite
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus.
Not available
S-EPMC4701850
|
biostudies-literature
Cite
Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.
Not available
S-EPMC4701848
|
biostudies-literature
Cite
Characteristics Associated With Detectable High‐Sensitivity Cardiac Troponin in Patients With Rheumatoid Arthritis at Low‐Intermediate Cardiac Risk
Not available
S-EPMC12317461
|
biostudies-literature
Cite
Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes.
Not available
S-EPMC4800739
|
biostudies-literature
Cite
Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis.
Not available
S-EPMC12615325
|
biostudies-literature
Cite
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies.
Not available
S-EPMC4021426
|
biostudies-literature
Cite
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.
Not available
S-EPMC4282288
|
biostudies-literature
Cite
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
Not available
S-EPMC8256627
|
biostudies-literature
Cite
Capturing and Documenting the Wider Health Impacts of the COVID-19 Pandemic Through the Remember Rebuild Saskatchewan Initiative: Protocol for a Mixed Methods Interdisciplinary Project.
Not available
S-EPMC10282902
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets